fbpx
August 23, 2022

Early AF Rhythm-Control Advantage Climbs With Comorbidity Burden Early AF Rhythm-Control Advantage Climbs With Comorbidity Burden

Although an early rhythm-control strategy outperformed a primarily rate-control approach for cardiovascular (CV) outcomes in patients with recent-onset atrial fibrillation (AF) in a recent trial, the […]
August 23, 2022

Brief Psychiatric Rating Scale Succeeds as Transdiagnostic Measure Brief Psychiatric Rating Scale Succeeds as Transdiagnostic Measure

The Brief Psychiatric Rating Scale (BPRS) was an effective tool for measuring general and specific psychiatric symptoms across the diagnostic spectrum, based on data from 600 […]
August 23, 2022

BioNTech Pursues Universal Vaccines and Oncologic Research BioNTech Pursues Universal Vaccines and Oncologic Research

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. BioNTech recently published its figures from the second quarter of 2022, as […]
August 23, 2022

New International Consensus Document on Treating OSA New International Consensus Document on Treating OSA

The Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) has issued a new international consensus document (ICD) on obstructive sleep apnea (OSA). The objective is to […]
August 23, 2022

Stingrays Are Not As Silent As Believed Stingrays Are Not As Silent As Believed

Stingrays appear to glide silently through oceans, but a group of researchers in Australia have found that rays can make sounds, especially when under duress. Social […]
August 23, 2022

New Adrenalectomy Guidelines Cover Surgery, Multispecialty Care New Adrenalectomy Guidelines Cover Surgery, Multispecialty Care

New adrenalectomy guidelines from the American Association of Endocrine Surgeons are aimed at assisting both specialist and general surgeons with perioperative adrenal care, including guidance on […]
August 23, 2022

Medical Assistance in Dying in Canada: Too Much, Too Fast? Medical Assistance in Dying in Canada: Too Much, Too Fast?

Canada will expand eligibility for medical assistance in dying (MAID) in 2023 to include individuals with a mental disorder as the sole underlying condition. The change […]
August 23, 2022

FDA Clears New Neurostimulation System for Chronic Pain FDA Clears New Neurostimulation System for Chronic Pain

The US Food and Drug Administration (FDA) has approved Abbott Laboratories’ new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy for the treatment of […]
August 23, 2022

Erlotinib Promising for Cancer Prevention in FAP Erlotinib Promising for Cancer Prevention in FAP

Use of the epidermal growth-factor receptor inhibitor erlotinib led to about a 30% reduction in duodenal polyp burden after 6 months of once-weekly treatment for patients […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0